| |
Review Journal “Penetration” Special Issue 2015
The special 2015 edition of Penetration celebrates more than two decades of continuous use of the extremely effective and globally useful antimicrobial, levofloxacin. This issue summarizes the reviews and interviews published in all issues of Penetration, including latest data reported through 2015.
(July 30, 2015)
Optimal Strategic Therapy for Community-Acquired Pneumonia: Levofloxacin at the Forefront of Fluoroquinolone CAP Therapy
(Chaired by Dr. Moh. Arifin Nawas, SpP(K), MARS)
(February 17, 2015)
New Treatment Strategies for the Eradication of Helicobacter pylori—Combating the Global Trend of Antibiotic Resistance
(November 7, 2013)
Levofloxacin: a Mainstay of Fluoroquinolone-Based Therapy—After Twenty Years of Use, Levofloxacin Remains Safe and Effective
(Moderated by Kurt G. Naber, MD, PhD)
(September 4, 2013)
Viewing Infectious Respiratory Disease
(Supervised by Prof. Jiro Fujita, MD, PhD, ACCP)
Effect of Combination of Levofloxacin and
Meropenem against Pseudomonas aeruginosa
(Supervised by Prof. Kazuhiro Tateda, MD, PhD)
The Treatment of Community-Acquired Pneumonia with Consideration of Mycobacterium tuberculosis: Risk Management in the Treatment of Pneumonia-Avoiding the Masking of TB by Antimicrobials
(Co-Chaired by Thomas Chang-Yao Tsao, MD, PhD and Shang-Jyh Kao, MD)
|
